Rating History for Eloxx Pharma (ELOX) by Guggenheim

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/20/2026 Vamil Divan New Coverage Buy
(N/A)
43.00
(N/A)
12.02
(12.81)
6.57% Details